Global Biotech Stocks

PYC Therapeutics

Market Cap: AU$577.4m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Clinuvel Pharmaceuticals

Market Cap: AU$566.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Shanghai Kai Kai Industry

Market Cap: CN¥2.6b

Engages in the production, distribution, and sale of pharmaceutical and clothing products in China.

Pacific Biosciences of California

Market Cap: US$366.5m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Aura Biosciences

Market Cap: US$365.3m

A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.

Benitec Biopharma

Market Cap: US$362.3m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

ShanXi C&Y Pharmaceutical GroupLTD

Market Cap: CN¥2.6b

Engages in the research, development, production, and sale of medicine and health food products.

Hangzhou Jiuyuan Genetic Biopharmaceutical

Market Cap: HK$2.8b

A biopharmaceutical company, engages in the research, development, production, and sale of biopharmaceutical products and medical devices.

Cullinan Therapeutics

Market Cap: US$353.9m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

DiaMedica Therapeutics

Market Cap: US$353.6m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Mesa Laboratories

Market Cap: US$352.9m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Senores Pharmaceuticals

Market Cap: ₹31.0b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Design Therapeutics

Market Cap: US$348.0m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Altimmune

Market Cap: US$346.0m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

JW Pharmaceutical

Market Cap: ₩487.2b

Manufactures and sells medicines and medical supplies in Japan and internationally.

Flerie

Market Cap: SEK 3.2b

A venture capital firm specializing in early-stage investments.

Rocket Pharmaceuticals

Market Cap: US$344.2m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

IOL Chemicals and Pharmaceuticals

Market Cap: ₹30.5b

Manufactures and sells pharmaceutical and chemical products in India and internationally.

Acepodia

Market Cap: NT$10.3b

Operates as a clinical stage biotechnology company.

Chengdu huasun technology group

Market Cap: CN¥2.4b

Chengdu huasun technology group Inc. , LTD.

enGene Holdings

Market Cap: US$332.7m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.1b

Standard Chemical & Pharmaceutical Co. Ltd.

Improve Medical Instruments

Market Cap: CN¥2.3b

Engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally.

Jiangsu Sihuan Bioengineering

Market Cap: CN¥2.3b

Engages in the pharmaceutical business in China.

Euroapi

Market Cap: €278.2m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

High Tide

Market Cap: CA$453.0m

Engages in the cannabis retail business in Canada.

Deva Holding

Market Cap: ₺13.4b

Manufactures, markets, and sells pharmaceutical products in Turkey.

Amarin

Market Cap: US$319.5m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

Celon Pharma

Market Cap: zł1.2b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.

Replimune Group

Market Cap: US$316.1m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.

PharmaEngine

Market Cap: NT$9.5b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Imexpharm

Market Cap: ₫8.2t

Manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally.

Vicore Pharma Holding

Market Cap: SEK 2.9b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Alpha Teknova

Market Cap: US$309.9m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Duopharma Biotech Berhad

Market Cap: RM 1.3b

An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.

Annexon

Market Cap: US$306.6m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.